Filing Details

Accession Number:
0000899243-21-038196
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-29 16:58:16
Reporting Period:
2021-09-27
Accepted Time:
2021-09-29 16:58:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1673772 Rapt Therapeutics Inc. RAPT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1182464 V David Goeddel 1 Letterman Drive
Building D, Suite Dm-900
San Francisco CA 94129
No No Yes No
1600420 Column Group Ii, Lp 1 Letterman Drive
Building D, Suite Dm-900
San Francisco CA 94129
No No Yes No
1606074 Peter Svennilson 1 Letterman Drive
Building D, Suite Dm-900
San Francisco CA 94129
No No Yes No
1614186 Tim Kutzkey 1 Letterman Drive
Building D, Suite Dm-900
San Francisco CA 94129
No No Yes No
1645333 Column Group Ii Gp, Lp 1 Letterman Drive
Building D, Suite Dm-900
San Francisco CA 94129
No No Yes No
1707230 Ponoi Capital, Lp 1 Letterman Drive
Building D, Suite Dm-900
San Francisco CA 94129
No No Yes No
1720702 Ponoi Management, Llc 1 Letterman Drive
Building D, Suite Dm-900
San Francisco CA 94129
No No Yes No
1732601 Ponoi Capital Ii, Lp 1 Letterman Drive
Building D, Suite Dm-900
San Francisco CA 94129
No No Yes No
1746488 Ponoi Ii Management, Llc 1 Letterman Drive
Building D, Suite Dm-900
San Francisco CA 94129
No No Yes No
1833486 Column Group Llc 1 Letterman Drive
Building D, Suite Dm-900
San Francisco CA 94129
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-09-27 7,500 $28.27 7,500 No 4 M Indirect See Footnote
Common Stock Disposition 2021-09-27 7,500 $34.48 0 No 4 S Indirect See Footnote
Common Stock Acquisiton 2021-09-27 1,114 $22.20 1,114 No 4 M Indirect See Footnote
Common Stock Disposition 2021-09-27 1,114 $34.97 0 No 4 S Indirect See Footnote
Common Stock Acquisiton 2021-09-27 625 $19.30 625 No 4 M Indirect See Footnote
Common Stock Disposition 2021-09-27 625 $34.94 0 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect See Footnote
No 4 S Indirect See Footnote
No 4 M Indirect See Footnote
No 4 S Indirect See Footnote
No 4 M Indirect See Footnote
No 4 S Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-09-27 7,500 $0.00 7,500 $28.27
Common Stock Stock Option (Right to Buy) Disposition 2021-09-27 1,114 $0.00 1,114 $22.20
Common Stock Stock Option (Right to Buy) Disposition 2021-09-27 625 $0.00 625 $19.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,000 2030-06-17 No 4 M Indirect
1,115 2031-03-30 No 4 M Indirect
6,875 2031-05-27 No 4 M Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,402,008 Direct
Common Stock 163 Indirect See Footnote
Common Stock 1,599,417 Indirect See Footnote
Common Stock 145,401 Indirect See Footnote
Footnotes
  1. These securities are directly held by Peter Svennilson.
  2. The securities are directly held by The Column Group II, LP ("TCG II LP"). The Column Group II GP, LP ("TCG II GP") is the general partner of TCG II LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG II GP are David Goeddel and Peter Svennilson (collectively, the "TCG II GP Managing Partners"). The TCG II GP Managing Partners may be deemed to share voting and investment power with respect to such shares. TCG II GP and each of the TCG II GP Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.
  3. The securities are directly held The Column Group LLC ("TCG LLC"). The managing members of TCG LLC are the TCG II GP Managing Partners and Tim Kutzkey (collectively, the "Ponoi Managing Partners"). The Ponoi Managing Partners may be deemed to share voting and investment power with respect to such shares. Each of the Ponoi Managing Partners disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.
  4. The securities are directly held by Ponoi Capital, LP ("Ponoi LP"). Ponoi Management, LLC ("Ponoi LLC") is the general partner of Ponoi LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of Ponoi LLC are the Ponoi Managing Partners. The Ponoi Managing Partners may be deemed to share voting and investment power with respect to such shares. Ponoi LLC and the each of the Ponoi Managing Partners disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.
  5. The securities are directly held by Ponoi Capital II, LP ("Ponoi II LP"). Ponoi II Management, LLC ("Ponoi II LLC") is the general partner of Ponoi II LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of Ponoi II LLC are the Ponoi Managing Partners. The Ponoi Managing Partners may be deemed to share voting and investment power with respect to such shares. Ponoi II LLC and the each of the Ponoi Managing Partners disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.
  6. As of the transaction date, 7,500 of the shares subject to this option have vested.
  7. The option was granted to Peter Svennilson for his service as a member of the Issuer's board of directors.
  8. As of the transaction date, 1,114 of the shares subject to this option have vested.
  9. As of the transaction date, 625 of the shares subject to this option have vested.